W. H. Tian

4.3k total citations · 3 hit papers
25 papers, 1.1k citations indexed

About

W. H. Tian is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. H. Tian has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. H. Tian's work include RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). W. H. Tian is often cited by papers focused on RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). W. H. Tian collaborates with scholars based in China, United States and Hong Kong. W. H. Tian's co-authors include Yutian Zou, Yuhui Tang, Jindong Xie, Xiaoming Xie, Xinpei Deng, Shaoquan Zheng, Linyu Wu, Chau‐Wei Wong, Hailin Tang and Xinhua Xie and has published in prestigious journals such as Nature Communications, Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

W. H. Tian

22 papers receiving 1.1k citations

Hit Papers

Leveraging diverse cell-death patterns to predict the pro... 2022 2026 2023 2024 2022 2022 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery
    2022 248 citations Yutian Zou, Jindong Xie et al. profile →
  2. The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
    2022 191 citations Yutian Zou, Feng Ye et al. Advanced Science profile →
  3. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
    2022 167 citations Yutian Zou, Shaoquan Zheng et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. H. Tian China 16 666 421 415 360 194 25 1.1k
Yuhui Tang China 18 913 1.4× 471 1.1× 554 1.3× 430 1.2× 245 1.3× 28 1.4k
Sufei Zheng China 19 513 0.8× 359 0.9× 329 0.8× 472 1.3× 183 0.9× 31 988
Holger H.H. Erb Germany 17 626 0.9× 453 1.1× 393 0.9× 366 1.0× 145 0.7× 58 1.2k
Charles Pottier Belgium 14 539 0.8× 218 0.5× 299 0.7× 362 1.0× 155 0.8× 15 1.0k
Àlvaro Aytés Spain 17 928 1.4× 477 1.1× 493 1.2× 306 0.8× 114 0.6× 20 1.4k
Xinpei Deng China 22 1.1k 1.6× 474 1.1× 666 1.6× 504 1.4× 281 1.4× 51 1.7k
Ya‐Ru Miao China 6 822 1.2× 530 1.3× 432 1.0× 419 1.2× 356 1.8× 6 1.4k
Qianya Qi United States 17 530 0.8× 283 0.7× 434 1.0× 563 1.6× 227 1.2× 25 1.1k

Countries citing papers authored by W. H. Tian

Since Specialization
Citations

This map shows the geographic impact of W. H. Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. H. Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. H. Tian more than expected).

Fields of papers citing papers by W. H. Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. H. Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. H. Tian. The network helps show where W. H. Tian may publish in the future.

Co-authorship network of co-authors of W. H. Tian

This figure shows the co-authorship network connecting the top 25 collaborators of W. H. Tian. A scholar is included among the top collaborators of W. H. Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. H. Tian. W. H. Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jinyuan, David C. Lin, W. H. Tian, et al.. (2025). Airflow: A double-edged sword in shaping white tea quality. Food Chemistry X. 28. 102558–102558.
3.
Wu, Linyu, Shanshan Huang, W. H. Tian, et al.. (2024). PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer. Cell Death Discovery. 10(1). 7–7. 25 indexed citations
4.
Tian, W. H., Hailin Tang, Chao Zhang, et al.. (2024). RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer. Journal of Advanced Research. 72. 333–351. 18 indexed citations
5.
Wang, Jinyuan, Xinyu Feng, W. H. Tian, et al.. (2024). Another inner truth of shaking: Water migration and transformation-advanced physicochemical alterations in tea leaves. Food Chemistry. 467. 142338–142338. 6 indexed citations
6.
Tian, W. H., Jinyuan Wang, Hongzheng Lin, et al.. (2024). Different smoking processes with the special fuel rods: Impart a smoky aroma to Souchong black tea. Food Chemistry X. 25. 102142–102142. 1 indexed citations
7.
Zheng, Shaojie, Di Guo, Yu Liu, et al.. (2024). Full life cycle of uranium toward ore-soil-root-shoot system: A comprehensive review. Critical Reviews in Environmental Science and Technology. 55(2). 123–145. 6 indexed citations
8.
Tang, Jie, W. H. Tian, Shujie Huang, Ju Yang, & H. J. Yang. (2024). 760P Cadonilimab with neoadjuvant chemotherapy in advanced ovarian cancer patients (AK104-IIT-003): An open, prospective, single arm, phase II trial. Annals of Oncology. 35. S576–S576.
9.
Tian, W. H., Yuhui Tang, Jindong Xie, et al.. (2023). AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death and Disease. 14(12). 790–790. 17 indexed citations
10.
Tian, W. H., Yuhui Tang, Yanan Kong, et al.. (2023). Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. International Journal of Biological Sciences. 19(5). 1645–1663. 20 indexed citations
11.
Xie, Jindong, Xinpei Deng, Yuhui Tang, et al.. (2023). Advances in artificial intelligence to predict cancer immunotherapy efficacy. Frontiers in Immunology. 13. 1076883–1076883. 63 indexed citations
12.
Zheng, Shaoquan, Jie‐Ying Liang, Yuhui Tang, et al.. (2023). Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study. Clinical and Translational Medicine. 13(2). e1189–e1189. 42 indexed citations
13.
Zou, Yutian, Feng Ye, Yanan Kong, et al.. (2022). The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced Science. 10(5). e2203699–e2203699. 191 indexed citations breakdown →
14.
Zou, Yutian, Shaoquan Zheng, Xinhua Xie, et al.. (2022). N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nature Communications. 13(1). 2672–2672. 167 indexed citations breakdown →
15.
Xie, Jindong, Junsheng Zhang, W. H. Tian, et al.. (2022). The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance. International Journal of Molecular Sciences. 23(24). 15647–15647. 39 indexed citations
16.
Tian, W. H., Chao Zhang, Jindong Xie, et al.. (2022). Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature. Frontiers in Immunology. 13. 1056680–1056680. 15 indexed citations
17.
Xie, Jindong, W. H. Tian, Yuhui Tang, et al.. (2022). Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences. 9. 834593–834593. 35 indexed citations
18.
Zou, Yutian, Jindong Xie, W. H. Tian, et al.. (2022). Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 839986–839986. 7 indexed citations
19.
Zhang, Ling, Xinhua Jiang, Xiaoming Xie, et al.. (2021). The Impact of Preoperative Radiomics Signature on the Survival of Breast Cancer Patients With Residual Tumors After NAC. Frontiers in Oncology. 10. 523327–523327. 5 indexed citations
20.
Yu, Ping, Hailin Tang, Yutian Zou, et al.. (2020). Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study. Cancer Control. 27(1). 1148411931–1148411931. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuhui Tang Breakdown of academic impact, for papers by Sufei Zheng Breakdown of academic impact, for papers by Holger H.H. Erb Breakdown of academic impact, for papers by Charles Pottier Breakdown of academic impact, for papers by Àlvaro Aytés Breakdown of academic impact, for papers by Xinpei Deng Breakdown of academic impact, for papers by Ya‐Ru Miao Breakdown of academic impact, for papers by Qianya Qi
Rankless by CCL
2026